This suggests that a modest increase in circulating RBP4 secreted by the liver dose not impair glucose homeostasis and adipocytes are greater contributors to higher circulating levels of RBP4 in obesity (64). Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.